Similar articles

• Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?

  Vernillo A. Vernillo A. Am J Bioeth. 2009 Aug;9(8):45-7. doi: 10.1080/15265160902939933. Am J Bioeth. 2009. PMID: 19998162 No abstract available.
• The duty to disclose (even more) adverse clinical trial results.

  Hassoun N. Hassoun N. Am J Bioeth. 2009 Aug;9(8):33-4. doi: 10.1080/15265160902893874. Am J Bioeth. 2009. PMID: 19998155 No abstract available.
• The duty to disclose adverse clinical trial results.

  Liao SM, Sheehan M, Clarke S. Liao SM, et al. Am J Bioeth. 2009 Aug;9(8):24-32. doi: 10.1080/15265160902984988. Am J Bioeth. 2009. PMID: 19998154
• Committees for Ethics in Research involving human subjects.

  Hossne WS, Vieira S, De Freitas CB. Hossne WS, et al. J Int Bioethique. 2008 Mar-Jun;19(1-2):131-41, 200. J Int Bioethique. 2008. PMID: 18664006 Review.
• The standard of disclosure in human subject experimentation.

  Morin K. Morin K. J Leg Med. 1998 Jun;19(2):157-221. doi: 10.1080/01947649809511059. J Leg Med. 1998. PMID: 9658739 Review. No abstract available.